drug · small molecule
patient view →GLK-302
Phase 2updated 2mo agoby $GKOS GLAUKOS Corp🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 4 investigational indications.
targets
Muscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M3
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that